InChI=1S/C20H26O6/c1-6-10(2)18(22)25-15-9-20(5)16(26-20)8-13(21)11(3)7-14-17(15)12(4)19(23)24-14/h6-7,13-17,21H,4,8-9H2,1-3,5H3/b10-6+,11-7+/t13-,14-,15-,16-,17+,20-/m1/s1 |
DZTWAOVNNLDWNH-DRCJWTCISA-N |
[H][C@@]12C[C@@H](O)\C(C)=C\[C@@]3([H])OC(=O)C(=C)[C@]3([H])[C@@H](C[C@@]1(C)O2)OC(=O)C(\C)=C\C |
|
Eupatorium kiirunense
(IPNI:1009045-1)
|
See:
PubMed
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(1aR,3R,4E,5aR,8aR,9R,10aR)-3-hydroxy-4,10a-dimethyl-8-methylidene-7-oxo-1a,2,3,5a,7,8,8a,9,10,10a-decahydrooxireno[5,6]cyclodeca[1,2-b]furan-9-yl (2E)-2-methylbut-2-enoate
|
10-epoxy-6βH,7αH-helianga-4Z,11(13)-dien-6,12-olide
|
ChEBI
|
8β-tigloyloxy-3α-hydroxy-1α,10-epoxy-6βH,7αH-helianga-4Z,11(13)-dien-6,12-olide
|
ChEBI
|
11258336
|
Reaxys Registry Number
|
Reaxys
|
15921421
|
PubMed citation
|
Europe PMC
|
|